Summary by Futu AI
Alterity Therapeutics has released its updated corporate governance framework for the financial year ended June 30, 2024, demonstrating its commitment to maintaining high standards of corporate oversight and transparency. The company has disclosed its compliance with ASX Corporate Governance Council Principles through Appendix 4G filing.The framework includes comprehensive policies covering board structure, risk management, remuneration practices, and shareholder communications. Key features include maintaining a majority independent board, establishing audit and remuneration committees, and implementing robust risk management processes. The company has also updated its diversity policy, whistleblower policy, and anti-bribery measures.The corporate governance statement, approved by the board on September 26, 2024, is publicly available on the company's website, along with detailed disclosures of board charters, committee structures, and compliance with ASX listing rules. The framework emphasizes continuous improvement in governance practices and stakeholder engagement.
